LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Science
• Health & Fitness
• Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,626,432 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't see how the site brings in money.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

patients, cancer, article, immune, treatment, radiation, google, scholar, cells, cell, immunotherapy, study, responses, antigens, response, stratum, additional, antigenspecific, nsclc, phase, therapy, tumor, file, cas, lung, radiotherapy, table, patient, local, antigen, data, clinical, safety, time, trial, analysis, antibody, combination, active, combined, mrna, vaccine, fig, ics, germany, nonsmall, antibodies, mrnabased, received, efficacy,

Topics {✒️}

vaccine-mediated t-cell killing fluorescein isothiocyanate anti-ifn-γ anti-pd1/-pd-l1 antibodies multi-functional rabies-specific cd4+ sequence-optimized mrna formulated mrna-based vaccines synergize protamine-based mrna immunotherapies enzyme-linked immunosorbent spot needle-free injection device key show fold-increases small-cell lung cancer sequence-optimized mrna encoding sequence-optimized mrnas encoding combine mrna-based immunotherapy post-vaccine time point full size image enzyme-linked immunosorbent assay sigma-aldrich chemie gmbh chemotherapy/egfr-targeted agent tumor necrosis factor-α apc-h7 anti-cd3 anti-inflammatory m2 macrophages rnactive®-based cancer immunotherapy real-world treatment patterns post-vaccine immune responses combined mrna-based immunotherapy needle-free administration technique brilliant violet605 anti-cd69 antigen-specific therapies mage-a3 cancer immunotherapeutic antigen-specific immune reactions resected mage-a3-positive producing antigen-specific cellular personalized cancer immunotherapy antigen-specific immune responses stage iii/iv melanoma mrna-based vaccination approach active cancer immunotherapy synergistic anti-tumor effect article download pdf vaccine antigen-specific cd4+ treatment-emergent adverse events mrna rabies vaccine active cancer therapy immune-mediated abscopal effect starting egfr-tki therapy brilliant violet650 anti-cd8 antigen-specific antibody levels precursor mrna vaccine radiation-induced abscopal effect

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
         description:Preclinical studies demonstrate synergism between cancer immunotherapy and local radiation, enhancing anti-tumor effects and promoting immune responses. BI1361849 (CV9202) is an active cancer immunotherapeutic comprising protamine-formulated, sequence-optimized mRNA encoding six non-small cell lung cancer (NSCLC)-associated antigens (NY-ESO-1, MAGE-C1, MAGE-C2, survivin, 5T4, and MUC-1), intended to induce targeted immune responses. We describe a phase Ib clinical trial evaluating treatment with BI1361849 combined with local radiation in 26 stage IV NSCLC patients with partial response (PR)/stable disease (SD) after standard first-line therapy. Patients were stratified into three strata (1: non-squamous NSCLC, no epidermal growth factor receptor (EGFR) mutation, PR/SD after ≥4 cycles of platinum- and pemetrexed-based treatment [n = 16]; 2: squamous NSCLC, PR/SD after ≥4 cycles of platinum-based and non-platinum compound treatment [n = 8]; 3: non-squamous NSCLC, EGFR mutation, PR/SD after ≥3 and ≤ 6 months EGFR-tyrosine kinase inhibitor (TKI) treatment [n = 2]). Patients received intradermal BI1361849, local radiation (4 × 5 Gy), then BI1361849 until disease progression. Strata 1 and 3 also had maintenance pemetrexed or continued EGFR-TKI therapy, respectively. The primary endpoint was evaluation of safety; secondary objectives included assessment of clinical efficacy (every 6 weeks during treatment) and of immune response (on Days 1 [baseline], 19 and 61). Study treatment was well tolerated; injection site reactions and flu-like symptoms were the most common BI1361849-related adverse events. Three patients had grade 3 BI1361849-related adverse events (fatigue, pyrexia); there was one grade 3 radiation-related event (dysphagia). In comparison to baseline, immunomonitoring revealed increased BI1361849 antigen-specific immune responses in the majority of patients (84%), whereby antigen-specific antibody levels were increased in 80% and functional T cells in 40% of patients, and involvement of multiple antigen specificities was evident in 52% of patients. One patient had a partial response in combination with pemetrexed maintenance, and 46.2% achieved stable disease as best overall response. Best overall response was SD in 57.7% for target lesions. The results support further investigation of mRNA-based immunotherapy in NSCLC including combinations with immune checkpoint inhibitors. ClinicalTrials.gov identifier: NCT01915524 .
         datePublished:2019-02-08T00:00:00Z
         dateModified:2019-02-08T00:00:00Z
         pageStart:1
         pageEnd:14
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s40425-019-0520-5
         keywords:
            Clinical trial
            Hypofractionated radiotherapy
            Immunomonitoring
            mRNA active cancer immunotherapy
            Non-small cell lung cancer
            BI1361849
            CV9202
            Oncology
            Immunology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-019-0520-5/MediaObjects/40425_2019_520_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-019-0520-5/MediaObjects/40425_2019_520_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-019-0520-5/MediaObjects/40425_2019_520_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-019-0520-5/MediaObjects/40425_2019_520_Fig4_HTML.png
         isPartOf:
            name:Journal for ImmunoTherapy of Cancer
            issn:
               2051-1426
            volumeNumber:7
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Alexandros Papachristofilou
               affiliation:
                     name:University Hospital Basel
                     address:
                        name:Clinic of Radiotherapy and Radiation Oncology, University Hospital Basel, Basel, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Madeleine M. Hipp
               affiliation:
                     name:CureVac AG
                     address:
                        name:CureVac AG, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ute Klinkhardt
               affiliation:
                     name:CureVac AG
                     address:
                        name:CureVac AG, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Martin Früh
               affiliation:
                     name:Hospital of St Gallen, St Gallen and University of Bern
                     address:
                        name:Hospital of St Gallen, St Gallen and University of Bern, Bern, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Martin Sebastian
               affiliation:
                     name:University Hospital Frankfurt
                     address:
                        name:University Hospital Frankfurt, Frankfurt, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Christian Weiss
               affiliation:
                     name:University Hospital Frankfurt
                     address:
                        name:University Hospital Frankfurt, Frankfurt, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Miklos Pless
               affiliation:
                     name:Cantonal Hospital of Winterthur
                     address:
                        name:Cantonal Hospital of Winterthur, Winterthur, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Richard Cathomas
               affiliation:
                     name:Hospital Graubünden
                     address:
                        name:Hospital Graubünden, Chur, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wolfgang Hilbe
               affiliation:
                     name:Wilhelminenspital
                     address:
                        name:Medical Department, Center for Oncology and Hematology, Wilhelminenspital, Wien, Austria
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Georg Pall
               affiliation:
                     name:University Hospital Innsbruck
                     address:
                        name:University Hospital Innsbruck, Innsbruck, Austria
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Thomas Wehler
               affiliation:
                     name:University Medical Center Mainz
                     address:
                        name:Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jürgen Alt
               affiliation:
                     name:University Medical Center Mainz
                     address:
                        name:Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Helge Bischoff
               affiliation:
                     name:Thoraxklinik Heidelberg gGmbH
                     address:
                        name:Thoraxklinik Heidelberg gGmbH, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Michael Geißler
               affiliation:
                     name:Klinik für Allg Innere Medizin, Onkolologie/ Hämatologie, Gastroenterologie, Infektiologie
                     address:
                        name:Klinik für Allg Innere Medizin, Onkolologie/ Hämatologie, Gastroenterologie, Infektiologie, Esslingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Frank Griesinger
               affiliation:
                     name:Pius Hospital University
                     address:
                        name:Department Hematology and Oncology, Pius Hospital University, Oldenburg, Germany
                        type:PostalAddress
                     type:Organization
                     name:Medical Campus University of Oldenburg
                     address:
                        name:Department Internal Medicine-Oncology, Medical Campus University of Oldenburg, Oldenburg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Karl-Josef Kallen
               affiliation:
                     name:eTheRNA Immunotherapies NV
                     address:
                        name:eTheRNA Immunotherapies NV, Niel, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mariola Fotin-Mleczek
               affiliation:
                     name:CureVac AG
                     address:
                        name:CureVac AG, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Andreas Schröder
               affiliation:
                     name:CureVac AG
                     address:
                        name:CureVac AG, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Birgit Scheel
               affiliation:
                     name:CureVac AG
                     address:
                        name:CureVac AG, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Anke Muth
               affiliation:
                     name:CureVac AG
                     address:
                        name:CureVac AG, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tobias Seibel
               affiliation:
                     name:CureVac AG
                     address:
                        name:CureVac AG, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Claudia Stosnach
               affiliation:
                     name:CureVac AG
                     address:
                        name:CureVac AG, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Fatma Doener
               affiliation:
                     name:CureVac AG
                     address:
                        name:CureVac AG, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Henoch S. Hong
               affiliation:
                     name:CureVac AG
                     address:
                        name:CureVac AG, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sven D. Koch
               affiliation:
                     name:CureVac AG
                     address:
                        name:CureVac AG, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ulrike Gnad-Vogt
               affiliation:
                     name:CureVac AG
                     address:
                        name:CureVac AG, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Alfred Zippelius
               affiliation:
                     name:Medical Oncology, University Hospital Basel
                     address:
                        name:Medical Oncology, University Hospital Basel, Basel, Switzerland
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
      description:Preclinical studies demonstrate synergism between cancer immunotherapy and local radiation, enhancing anti-tumor effects and promoting immune responses. BI1361849 (CV9202) is an active cancer immunotherapeutic comprising protamine-formulated, sequence-optimized mRNA encoding six non-small cell lung cancer (NSCLC)-associated antigens (NY-ESO-1, MAGE-C1, MAGE-C2, survivin, 5T4, and MUC-1), intended to induce targeted immune responses. We describe a phase Ib clinical trial evaluating treatment with BI1361849 combined with local radiation in 26 stage IV NSCLC patients with partial response (PR)/stable disease (SD) after standard first-line therapy. Patients were stratified into three strata (1: non-squamous NSCLC, no epidermal growth factor receptor (EGFR) mutation, PR/SD after ≥4 cycles of platinum- and pemetrexed-based treatment [n = 16]; 2: squamous NSCLC, PR/SD after ≥4 cycles of platinum-based and non-platinum compound treatment [n = 8]; 3: non-squamous NSCLC, EGFR mutation, PR/SD after ≥3 and ≤ 6 months EGFR-tyrosine kinase inhibitor (TKI) treatment [n = 2]). Patients received intradermal BI1361849, local radiation (4 × 5 Gy), then BI1361849 until disease progression. Strata 1 and 3 also had maintenance pemetrexed or continued EGFR-TKI therapy, respectively. The primary endpoint was evaluation of safety; secondary objectives included assessment of clinical efficacy (every 6 weeks during treatment) and of immune response (on Days 1 [baseline], 19 and 61). Study treatment was well tolerated; injection site reactions and flu-like symptoms were the most common BI1361849-related adverse events. Three patients had grade 3 BI1361849-related adverse events (fatigue, pyrexia); there was one grade 3 radiation-related event (dysphagia). In comparison to baseline, immunomonitoring revealed increased BI1361849 antigen-specific immune responses in the majority of patients (84%), whereby antigen-specific antibody levels were increased in 80% and functional T cells in 40% of patients, and involvement of multiple antigen specificities was evident in 52% of patients. One patient had a partial response in combination with pemetrexed maintenance, and 46.2% achieved stable disease as best overall response. Best overall response was SD in 57.7% for target lesions. The results support further investigation of mRNA-based immunotherapy in NSCLC including combinations with immune checkpoint inhibitors. ClinicalTrials.gov identifier: NCT01915524 .
      datePublished:2019-02-08T00:00:00Z
      dateModified:2019-02-08T00:00:00Z
      pageStart:1
      pageEnd:14
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s40425-019-0520-5
      keywords:
         Clinical trial
         Hypofractionated radiotherapy
         Immunomonitoring
         mRNA active cancer immunotherapy
         Non-small cell lung cancer
         BI1361849
         CV9202
         Oncology
         Immunology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-019-0520-5/MediaObjects/40425_2019_520_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-019-0520-5/MediaObjects/40425_2019_520_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-019-0520-5/MediaObjects/40425_2019_520_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-019-0520-5/MediaObjects/40425_2019_520_Fig4_HTML.png
      isPartOf:
         name:Journal for ImmunoTherapy of Cancer
         issn:
            2051-1426
         volumeNumber:7
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Alexandros Papachristofilou
            affiliation:
                  name:University Hospital Basel
                  address:
                     name:Clinic of Radiotherapy and Radiation Oncology, University Hospital Basel, Basel, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Madeleine M. Hipp
            affiliation:
                  name:CureVac AG
                  address:
                     name:CureVac AG, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ute Klinkhardt
            affiliation:
                  name:CureVac AG
                  address:
                     name:CureVac AG, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Martin Früh
            affiliation:
                  name:Hospital of St Gallen, St Gallen and University of Bern
                  address:
                     name:Hospital of St Gallen, St Gallen and University of Bern, Bern, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Martin Sebastian
            affiliation:
                  name:University Hospital Frankfurt
                  address:
                     name:University Hospital Frankfurt, Frankfurt, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Christian Weiss
            affiliation:
                  name:University Hospital Frankfurt
                  address:
                     name:University Hospital Frankfurt, Frankfurt, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Miklos Pless
            affiliation:
                  name:Cantonal Hospital of Winterthur
                  address:
                     name:Cantonal Hospital of Winterthur, Winterthur, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Richard Cathomas
            affiliation:
                  name:Hospital Graubünden
                  address:
                     name:Hospital Graubünden, Chur, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wolfgang Hilbe
            affiliation:
                  name:Wilhelminenspital
                  address:
                     name:Medical Department, Center for Oncology and Hematology, Wilhelminenspital, Wien, Austria
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Georg Pall
            affiliation:
                  name:University Hospital Innsbruck
                  address:
                     name:University Hospital Innsbruck, Innsbruck, Austria
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Thomas Wehler
            affiliation:
                  name:University Medical Center Mainz
                  address:
                     name:Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jürgen Alt
            affiliation:
                  name:University Medical Center Mainz
                  address:
                     name:Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Helge Bischoff
            affiliation:
                  name:Thoraxklinik Heidelberg gGmbH
                  address:
                     name:Thoraxklinik Heidelberg gGmbH, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Michael Geißler
            affiliation:
                  name:Klinik für Allg Innere Medizin, Onkolologie/ Hämatologie, Gastroenterologie, Infektiologie
                  address:
                     name:Klinik für Allg Innere Medizin, Onkolologie/ Hämatologie, Gastroenterologie, Infektiologie, Esslingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Frank Griesinger
            affiliation:
                  name:Pius Hospital University
                  address:
                     name:Department Hematology and Oncology, Pius Hospital University, Oldenburg, Germany
                     type:PostalAddress
                  type:Organization
                  name:Medical Campus University of Oldenburg
                  address:
                     name:Department Internal Medicine-Oncology, Medical Campus University of Oldenburg, Oldenburg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Karl-Josef Kallen
            affiliation:
                  name:eTheRNA Immunotherapies NV
                  address:
                     name:eTheRNA Immunotherapies NV, Niel, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mariola Fotin-Mleczek
            affiliation:
                  name:CureVac AG
                  address:
                     name:CureVac AG, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Andreas Schröder
            affiliation:
                  name:CureVac AG
                  address:
                     name:CureVac AG, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Birgit Scheel
            affiliation:
                  name:CureVac AG
                  address:
                     name:CureVac AG, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Anke Muth
            affiliation:
                  name:CureVac AG
                  address:
                     name:CureVac AG, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tobias Seibel
            affiliation:
                  name:CureVac AG
                  address:
                     name:CureVac AG, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Claudia Stosnach
            affiliation:
                  name:CureVac AG
                  address:
                     name:CureVac AG, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Fatma Doener
            affiliation:
                  name:CureVac AG
                  address:
                     name:CureVac AG, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Henoch S. Hong
            affiliation:
                  name:CureVac AG
                  address:
                     name:CureVac AG, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sven D. Koch
            affiliation:
                  name:CureVac AG
                  address:
                     name:CureVac AG, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ulrike Gnad-Vogt
            affiliation:
                  name:CureVac AG
                  address:
                     name:CureVac AG, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Alfred Zippelius
            affiliation:
                  name:Medical Oncology, University Hospital Basel
                  address:
                     name:Medical Oncology, University Hospital Basel, Basel, Switzerland
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal for ImmunoTherapy of Cancer
      issn:
         2051-1426
      volumeNumber:7
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University Hospital Basel
      address:
         name:Clinic of Radiotherapy and Radiation Oncology, University Hospital Basel, Basel, Switzerland
         type:PostalAddress
      name:CureVac AG
      address:
         name:CureVac AG, Tübingen, Germany
         type:PostalAddress
      name:CureVac AG
      address:
         name:CureVac AG, Tübingen, Germany
         type:PostalAddress
      name:Hospital of St Gallen, St Gallen and University of Bern
      address:
         name:Hospital of St Gallen, St Gallen and University of Bern, Bern, Switzerland
         type:PostalAddress
      name:University Hospital Frankfurt
      address:
         name:University Hospital Frankfurt, Frankfurt, Germany
         type:PostalAddress
      name:University Hospital Frankfurt
      address:
         name:University Hospital Frankfurt, Frankfurt, Germany
         type:PostalAddress
      name:Cantonal Hospital of Winterthur
      address:
         name:Cantonal Hospital of Winterthur, Winterthur, Switzerland
         type:PostalAddress
      name:Hospital Graubünden
      address:
         name:Hospital Graubünden, Chur, Switzerland
         type:PostalAddress
      name:Wilhelminenspital
      address:
         name:Medical Department, Center for Oncology and Hematology, Wilhelminenspital, Wien, Austria
         type:PostalAddress
      name:University Hospital Innsbruck
      address:
         name:University Hospital Innsbruck, Innsbruck, Austria
         type:PostalAddress
      name:University Medical Center Mainz
      address:
         name:Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany
         type:PostalAddress
      name:University Medical Center Mainz
      address:
         name:Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany
         type:PostalAddress
      name:Thoraxklinik Heidelberg gGmbH
      address:
         name:Thoraxklinik Heidelberg gGmbH, Heidelberg, Germany
         type:PostalAddress
      name:Klinik für Allg Innere Medizin, Onkolologie/ Hämatologie, Gastroenterologie, Infektiologie
      address:
         name:Klinik für Allg Innere Medizin, Onkolologie/ Hämatologie, Gastroenterologie, Infektiologie, Esslingen, Germany
         type:PostalAddress
      name:Pius Hospital University
      address:
         name:Department Hematology and Oncology, Pius Hospital University, Oldenburg, Germany
         type:PostalAddress
      name:Medical Campus University of Oldenburg
      address:
         name:Department Internal Medicine-Oncology, Medical Campus University of Oldenburg, Oldenburg, Germany
         type:PostalAddress
      name:eTheRNA Immunotherapies NV
      address:
         name:eTheRNA Immunotherapies NV, Niel, Belgium
         type:PostalAddress
      name:CureVac AG
      address:
         name:CureVac AG, Tübingen, Germany
         type:PostalAddress
      name:CureVac AG
      address:
         name:CureVac AG, Tübingen, Germany
         type:PostalAddress
      name:CureVac AG
      address:
         name:CureVac AG, Tübingen, Germany
         type:PostalAddress
      name:CureVac AG
      address:
         name:CureVac AG, Tübingen, Germany
         type:PostalAddress
      name:CureVac AG
      address:
         name:CureVac AG, Tübingen, Germany
         type:PostalAddress
      name:CureVac AG
      address:
         name:CureVac AG, Tübingen, Germany
         type:PostalAddress
      name:CureVac AG
      address:
         name:CureVac AG, Tübingen, Germany
         type:PostalAddress
      name:CureVac AG
      address:
         name:CureVac AG, Tübingen, Germany
         type:PostalAddress
      name:CureVac AG
      address:
         name:CureVac AG, Tübingen, Germany
         type:PostalAddress
      name:CureVac AG
      address:
         name:CureVac AG, Tübingen, Germany
         type:PostalAddress
      name:Medical Oncology, University Hospital Basel
      address:
         name:Medical Oncology, University Hospital Basel, Basel, Switzerland
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Alexandros Papachristofilou
      affiliation:
            name:University Hospital Basel
            address:
               name:Clinic of Radiotherapy and Radiation Oncology, University Hospital Basel, Basel, Switzerland
               type:PostalAddress
            type:Organization
      name:Madeleine M. Hipp
      affiliation:
            name:CureVac AG
            address:
               name:CureVac AG, Tübingen, Germany
               type:PostalAddress
            type:Organization
      name:Ute Klinkhardt
      affiliation:
            name:CureVac AG
            address:
               name:CureVac AG, Tübingen, Germany
               type:PostalAddress
            type:Organization
      name:Martin Früh
      affiliation:
            name:Hospital of St Gallen, St Gallen and University of Bern
            address:
               name:Hospital of St Gallen, St Gallen and University of Bern, Bern, Switzerland
               type:PostalAddress
            type:Organization
      name:Martin Sebastian
      affiliation:
            name:University Hospital Frankfurt
            address:
               name:University Hospital Frankfurt, Frankfurt, Germany
               type:PostalAddress
            type:Organization
      name:Christian Weiss
      affiliation:
            name:University Hospital Frankfurt
            address:
               name:University Hospital Frankfurt, Frankfurt, Germany
               type:PostalAddress
            type:Organization
      name:Miklos Pless
      affiliation:
            name:Cantonal Hospital of Winterthur
            address:
               name:Cantonal Hospital of Winterthur, Winterthur, Switzerland
               type:PostalAddress
            type:Organization
      name:Richard Cathomas
      affiliation:
            name:Hospital Graubünden
            address:
               name:Hospital Graubünden, Chur, Switzerland
               type:PostalAddress
            type:Organization
      name:Wolfgang Hilbe
      affiliation:
            name:Wilhelminenspital
            address:
               name:Medical Department, Center for Oncology and Hematology, Wilhelminenspital, Wien, Austria
               type:PostalAddress
            type:Organization
      name:Georg Pall
      affiliation:
            name:University Hospital Innsbruck
            address:
               name:University Hospital Innsbruck, Innsbruck, Austria
               type:PostalAddress
            type:Organization
      name:Thomas Wehler
      affiliation:
            name:University Medical Center Mainz
            address:
               name:Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany
               type:PostalAddress
            type:Organization
      name:Jürgen Alt
      affiliation:
            name:University Medical Center Mainz
            address:
               name:Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany
               type:PostalAddress
            type:Organization
      name:Helge Bischoff
      affiliation:
            name:Thoraxklinik Heidelberg gGmbH
            address:
               name:Thoraxklinik Heidelberg gGmbH, Heidelberg, Germany
               type:PostalAddress
            type:Organization
      name:Michael Geißler
      affiliation:
            name:Klinik für Allg Innere Medizin, Onkolologie/ Hämatologie, Gastroenterologie, Infektiologie
            address:
               name:Klinik für Allg Innere Medizin, Onkolologie/ Hämatologie, Gastroenterologie, Infektiologie, Esslingen, Germany
               type:PostalAddress
            type:Organization
      name:Frank Griesinger
      affiliation:
            name:Pius Hospital University
            address:
               name:Department Hematology and Oncology, Pius Hospital University, Oldenburg, Germany
               type:PostalAddress
            type:Organization
            name:Medical Campus University of Oldenburg
            address:
               name:Department Internal Medicine-Oncology, Medical Campus University of Oldenburg, Oldenburg, Germany
               type:PostalAddress
            type:Organization
      name:Karl-Josef Kallen
      affiliation:
            name:eTheRNA Immunotherapies NV
            address:
               name:eTheRNA Immunotherapies NV, Niel, Belgium
               type:PostalAddress
            type:Organization
      name:Mariola Fotin-Mleczek
      affiliation:
            name:CureVac AG
            address:
               name:CureVac AG, Tübingen, Germany
               type:PostalAddress
            type:Organization
      name:Andreas Schröder
      affiliation:
            name:CureVac AG
            address:
               name:CureVac AG, Tübingen, Germany
               type:PostalAddress
            type:Organization
      name:Birgit Scheel
      affiliation:
            name:CureVac AG
            address:
               name:CureVac AG, Tübingen, Germany
               type:PostalAddress
            type:Organization
      name:Anke Muth
      affiliation:
            name:CureVac AG
            address:
               name:CureVac AG, Tübingen, Germany
               type:PostalAddress
            type:Organization
      name:Tobias Seibel
      affiliation:
            name:CureVac AG
            address:
               name:CureVac AG, Tübingen, Germany
               type:PostalAddress
            type:Organization
      name:Claudia Stosnach
      affiliation:
            name:CureVac AG
            address:
               name:CureVac AG, Tübingen, Germany
               type:PostalAddress
            type:Organization
      name:Fatma Doener
      affiliation:
            name:CureVac AG
            address:
               name:CureVac AG, Tübingen, Germany
               type:PostalAddress
            type:Organization
      name:Henoch S. Hong
      affiliation:
            name:CureVac AG
            address:
               name:CureVac AG, Tübingen, Germany
               type:PostalAddress
            type:Organization
      name:Sven D. Koch
      affiliation:
            name:CureVac AG
            address:
               name:CureVac AG, Tübingen, Germany
               type:PostalAddress
            type:Organization
      name:Ulrike Gnad-Vogt
      affiliation:
            name:CureVac AG
            address:
               name:CureVac AG, Tübingen, Germany
               type:PostalAddress
            type:Organization
      name:Alfred Zippelius
      affiliation:
            name:Medical Oncology, University Hospital Basel
            address:
               name:Medical Oncology, University Hospital Basel, Basel, Switzerland
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Clinic of Radiotherapy and Radiation Oncology, University Hospital Basel, Basel, Switzerland
      name:CureVac AG, Tübingen, Germany
      name:CureVac AG, Tübingen, Germany
      name:Hospital of St Gallen, St Gallen and University of Bern, Bern, Switzerland
      name:University Hospital Frankfurt, Frankfurt, Germany
      name:University Hospital Frankfurt, Frankfurt, Germany
      name:Cantonal Hospital of Winterthur, Winterthur, Switzerland
      name:Hospital Graubünden, Chur, Switzerland
      name:Medical Department, Center for Oncology and Hematology, Wilhelminenspital, Wien, Austria
      name:University Hospital Innsbruck, Innsbruck, Austria
      name:Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany
      name:Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany
      name:Thoraxklinik Heidelberg gGmbH, Heidelberg, Germany
      name:Klinik für Allg Innere Medizin, Onkolologie/ Hämatologie, Gastroenterologie, Infektiologie, Esslingen, Germany
      name:Department Hematology and Oncology, Pius Hospital University, Oldenburg, Germany
      name:Department Internal Medicine-Oncology, Medical Campus University of Oldenburg, Oldenburg, Germany
      name:eTheRNA Immunotherapies NV, Niel, Belgium
      name:CureVac AG, Tübingen, Germany
      name:CureVac AG, Tübingen, Germany
      name:CureVac AG, Tübingen, Germany
      name:CureVac AG, Tübingen, Germany
      name:CureVac AG, Tübingen, Germany
      name:CureVac AG, Tübingen, Germany
      name:CureVac AG, Tübingen, Germany
      name:CureVac AG, Tübingen, Germany
      name:CureVac AG, Tübingen, Germany
      name:CureVac AG, Tübingen, Germany
      name:Medical Oncology, University Hospital Basel, Basel, Switzerland

External Links {🔗}(175)

• What are the total earnings of https://www.springernature.com/gp/authors?
• What are the total earnings of https://link.springernature.com/home/?
• Profit of https://order.springer.com/public/cart
• Earnings of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research
• How much does https://clinicaltrials.gov/ct2/show/NCT01915524 make?
• What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27471692?
• How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928356 make?
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=Therapeutic%20vaccines%20in%20non-small%20cell%20lung%20cancer&journal=Immunotargets%20Ther&volume=2&pages=115-124&publication_year=2013&author=Socola%2CF&author=Scherfenberg%2CN&author=Raez%2CLE?
• How much profit is https://doi.org/10.1016%2FS1470-2045%2813%2970510-2 making per month?
• http://scholar.google.com/scholar_lookup?&title=Tecemotide%20%28L-BLP25%29%20versus%20placebo%20after%20chemoradiotherapy%20for%20stage%20III%20non-small-cell%20lung%20cancer%20%28START%29%3A%20a%20randomised%2C%20double-blind%2C%20phase%203%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2813%2970510-2&volume=15&pages=59-68&publication_year=2014&author=Butts%2CC&author=Socinski%2CMA&author=Mitchell%2CPL&author=Thatcher%2CN&author=Havel%2CL&author=Krzakowski%2CM's financial summary
• Financial intake of https://doi.org/10.1016%2FS1470-2045%2816%2900099-1
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=Efficacy%20of%20the%20MAGE-A3%20cancer%20immunotherapeutic%20as%20adjuvant%20therapy%20in%20patients%20with%20resected%20MAGE-A3-positive%20non-small-cell%20lung%20cancer%20%28MAGRIT%29%3A%20a%20randomised%2C%20double-blind%2C%20placebo-controlled%2C%20phase%203%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2816%2900099-1&volume=17&pages=822-835&publication_year=2016&author=Vansteenkiste%2CJF&author=Cho%2CBC&author=Vanakesa%2CT&author=Pas%2CT&author=Zielinski%2CM&author=Kim%2CMS
• What's https://doi.org/10.1158%2F0008-5472.CAN-12-1952's gross income?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Changing%20the%20tumor%20microenvironment%3A%20new%20strategies%20for%20immunotherapy&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-12-1952&volume=72&pages=5159-5164&publication_year=2012&author=Berraondo%2CP&author=Umansky%2CV&author=Melero%2CI produce monthly?
• How much does https://doi.org/10.1002%2F1521-4141%28200001%2930%3A1%3C1%3A%3AAID-IMMU1%3E3.0.CO%3B2-%23 generate monthly?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=In%20vivo%20application%20of%20RNA%20leads%20to%20induction%20of%20specific%20cytotoxic%20T%20lymphocytes%20and%20antibodies&journal=Eur%20J%20Immunol&doi=10.1002%2F1521-4141%28200001%2930%3A1%3C1%3A%3AAID-IMMU1%3E3.0.CO%3B2-%23&volume=30&pages=1-7&publication_year=2000&author=Hoerr%2CI&author=Obst%2CR&author=Rammensee%2CHG&author=Jung%2CG
• How profitable is http://scholar.google.com/scholar_lookup?&title=Self-adjuvanted%20mRNA%20vaccination%20in%20advanced%20prostate%20cancer%20patients%3A%20a%20first-in-man%20phase%20I%2FIIa%20study&journal=J%20Immunother%20Cancer&doi=10.1186%2Fs40425-015-0068-y&volume=3&publication_year=2015&author=K%C3%BCbler%2CH&author=Scheel%2CB&author=Gnad-Vogt%2CU&author=Miller%2CK&author=Schultze-Seemann%2CW&author=Vom%20Dorp%2CF?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Phase%20Ib%20study%20evaluating%20a%20self-adjuvanted%20mRNA%20cancer%20vaccine%20%28RNActive%C2%AE%29%20combined%20with%20local%20radiation%20as%20consolidation%20and%20maintenance%20treatment%20for%20patients%20with%20stage%20IV%20non-small%20cell%20lung%20cancer&journal=BMC%20Cancer&doi=10.1186%2F1471-2407-14-748&volume=14&publication_year=2014&author=Sebastian%2CM&author=Papachristofilou%2CA&author=Weiss%2CC&author=Fr%C3%BCh%2CM&author=Cathomas%2CR&author=Hilbe%2CW make?
• What's the financial intake of https://doi.org/10.1080%2F2162402X.2016.1249560?
• How much does http://scholar.google.com/scholar_lookup?&title=Distinct%20transcriptional%20changes%20in%20non-small%20cell%20lung%20cancer%20patients%20associated%20with%20multi-antigenic%20RNActive%C2%AE%20CV9201%20immunotherapy&journal=Oncoimmunology&doi=10.1080%2F2162402X.2016.1249560&volume=5&publication_year=2016&author=Hong%2CHS&author=Koch%2CSD&author=Scheel%2CB&author=Gnad-Vogt%2CU&author=Schr%C3%B6der%2CA&author=Kallen%2CK-J generate monthly?
• How much does https://doi.org/10.4161%2Fhv.25181 earn?
• What's the income generated by http://scholar.google.com/scholar_lookup?&title=A%20novel%2C%20disruptive%20vaccination%20technology%3A%20self-adjuvanted%20RNActive%28%C2%AE%29%20vaccines&journal=Hum%20Vaccin%20Immunother&doi=10.4161%2Fhv.25181&volume=9&pages=2263-2276&publication_year=2013&author=Kallen%2CK-J&author=Heidenreich%2CR&author=Schnee%2CM&author=Petsch%2CB&author=Schlake%2CT&author=Thess%2CA each month?
• Income figures for https://doi.org/10.1016%2FS1470-2045%2815%2900483-0
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=TG4010%20immunotherapy%20and%20first-line%20chemotherapy%20for%20advanced%20non-small-cell%20lung%20cancer%20%28TIME%29%3A%20results%20from%20the%20phase%202b%20part%20of%20a%20randomised%2C%20double-blind%2C%20placebo-controlled%2C%20phase%202b%2F3%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2815%2900483-0&volume=17&pages=212-223&publication_year=2016&author=Quoix%2CE&author=Lena%2CH&author=Losonczy%2CG&author=Forget%2CF&author=Chouaid%2CC&author=Papai%2CZ?
• Discover the revenue of https://doi.org/10.1038%2Fnature11404
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Comprehensive%20genomic%20characterization%20of%20squamous%20cell%20lung%20cancers&journal=Nature&doi=10.1038%2Fnature11404&volume=489&pages=519-525&publication_year=2012
• Income figures for https://doi.org/10.1158%2F1078-0432.CCR-12-2321
• Income figures for http://scholar.google.com/scholar_lookup?&title=A%2012-gene%20set%20predicts%20survival%20benefits%20from%20adjuvant%20chemotherapy%20in%20non-small%20cell%20lung%20cancer%20patients&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-12-2321&volume=19&pages=1577-1586&publication_year=2013&author=Tang%2CH&author=Xiao%2CG&author=Behrens%2CC&author=Schiller%2CJ&author=Allen%2CJ&author=Chow%2CC-W
• How much does https://doi.org/10.1080%2F02841860600604611 bring in each month?
• How much money does http://scholar.google.com/scholar_lookup?&title=Regression%20of%20non-irradiated%20metastases%20after%20extracranial%20stereotactic%20radiotherapy%20in%20metastatic%20renal%20cell%20carcinoma&journal=Acta%20Oncol&doi=10.1080%2F02841860600604611&volume=45&pages=493-497&publication_year=2006&author=Wers%C3%A4ll%2CPJ&author=Blomgren%2CH&author=Pisa%2CP&author=Lax%2CI&author=K%C3%A4lkner%2CK-M&author=Svedman%2CC make?
• How much revenue does https://doi.org/10.1016%2Fj.ijrobp.2012.06.020 generate?
• See how much http://scholar.google.com/scholar_lookup?&title=Radiation%20therapy%20to%20convert%20the%20tumor%20into%20an%20in%20situ%20vaccine&journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&doi=10.1016%2Fj.ijrobp.2012.06.020&volume=84&pages=879-880&publication_year=2012&author=Formenti%2CSC&author=Demaria%2CS makes per month
• How much cash flow does https://doi.org/10.1001%2Fjamaoncol.2015.2756 have monthly?
• What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Role%20of%20local%20radiation%20therapy%20in%20cancer%20immunotherapy&journal=JAMA%20Oncol&doi=10.1001%2Fjamaoncol.2015.2756&volume=1&pages=1325-1332&publication_year=2015&author=Demaria%2CS&author=Golden%2CEB&author=Formenti%2CSC?
• How much revenue does https://doi.org/10.1158%2F0008-5472.CAN-04-0073 produce monthly?
• How profitable is http://scholar.google.com/scholar_lookup?&title=External%20beam%20radiation%20of%20tumors%20alters%20phenotype%20of%20tumor%20cells%20to%20render%20them%20susceptible%20to%20vaccine-mediated%20T-cell%20killing&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-04-0073&volume=64&pages=4328-4337&publication_year=2004&author=Chakraborty%2CM&author=Abrams%2CSI&author=Coleman%2CCN&author=Camphausen%2CK&author=Schlom%2CJ&author=Hodge%2CJW?
• Check the income stats for https://doi.org/10.1158%2F1078-0432.CCR-09-0265
• What's the income of http://scholar.google.com/scholar_lookup?&title=Fractionated%20but%20not%20single-dose%20radiotherapy%20induces%20an%20immune-mediated%20abscopal%20effect%20when%20combined%20with%20anti-CTLA-4%20antibody&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-09-0265&volume=15&pages=5379-5388&publication_year=2009&author=Dewan%2CMZ&author=Galloway%2CAE&author=Kawashima%2CN&author=Dewyngaert%2CJK&author=Babb%2CJS&author=Formenti%2CSC?
• How much cash flow does https://doi.org/10.1200%2FJCO.2010.28.9793 have monthly?
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=In%20situ%20vaccination%20with%20a%20TLR9%20agonist%20induces%20systemic%20lymphoma%20regression%3A%20a%20phase%20I%2FII%20study&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2010.28.9793&volume=28&pages=4324-4332&publication_year=2010&author=Brody%2CJD&author=Ai%2CWZ&author=Czerwinski%2CDK&author=Torchia%2CJA&author=Levy%2CM&author=Advani%2CRH?
• How much profit does http://scholar.google.com/scholar_lookup?&title=mRNA-based%20vaccines%20synergize%20with%20radiation%20therapy%20to%20eradicate%20established%20tumors&journal=Radiat%20Oncol&doi=10.1186%2F1748-717X-9-180&volume=9&publication_year=2014&author=Fotin-Mleczek%2CM&author=Zanzinger%2CK&author=Heidenreich%2CR&author=Lorenz%2CC&author=Kowalczyk%2CA&author=Kallen%2CK-J generate?
• See how much http://scholar.google.com/scholar_lookup?&title=Abscopal%20effects%20of%20radiotherapy%20and%20combined%20mRNA-based%20immunotherapy%20in%20a%20syngeneic%2C%20OVA-expressing%20thymoma%20mouse%20model&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-018-2117-0&volume=67&pages=653-662&publication_year=2018&author=Basler%2CL&author=Kowalczyk%2CA&author=Heidenreich%2CR&author=Fotin-Mleczek%2CM&author=Tsitsekidis%2CS&author=Zips%2CD makes per month
• Income figures for https://doi.org/10.1056%2FNEJMoa1112824
• Earnings of http://scholar.google.com/scholar_lookup?&title=Immunologic%20correlates%20of%20the%20abscopal%20effect%20in%20a%20patient%20with%20melanoma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1112824&volume=366&pages=925-931&publication_year=2012&author=Postow%2CMA&author=Callahan%2CMK&author=Barker%2CCA&author=Yamada%2CY&author=Yuan%2CJ&author=Kitano%2CS
• What is the monthly revenue of https://doi.org/10.1158%2F2326-6066.CIR-13-0115?
• What's the income of http://scholar.google.com/scholar_lookup?&title=An%20abscopal%20response%20to%20radiation%20and%20ipilimumab%20in%20a%20patient%20with%20metastatic%20non-small%20cell%20lung%20cancer&journal=Cancer%20Immunol%20Res&doi=10.1158%2F2326-6066.CIR-13-0115&volume=1&pages=365-372&publication_year=2013&author=Golden%2CEB&author=Demaria%2CS&author=Schiff%2CPB&author=Chachoua%2CA&author=Formenti%2CSC?
• How much profit does https://doi.org/10.1097%2FJTO.0000000000000686 generate?
• Get to know http://scholar.google.com/scholar_lookup?&title=Clinical%20trials%20integrating%20immunotherapy%20and%20radiation%20for%20non-small-cell%20lung%20cancer&journal=J%20Thorac%20Oncol&doi=10.1097%2FJTO.0000000000000686&volume=10&pages=1685-1693&publication_year=2015&author=Daly%2CME&author=Monjazeb%2CAM&author=Kelly%2CK's earnings
• How much does https://doi.org/10.1016%2Fj.it.2018.06.001 pull in monthly?
• http://scholar.google.com/scholar_lookup?&title=Immunological%20mechanisms%20responsible%20for%20radiation-induced%20Abscopal%20effect&journal=Trends%20Immunol&doi=10.1016%2Fj.it.2018.06.001&volume=39&pages=644-655&publication_year=2018&author=Rodr%C3%ADguez-Ruiz%2CME&author=Vanpouille-Box%2CC&author=Melero%2CI&author=Formenti%2CSC&author=Demaria%2CS's total income per month
• What's the monthly money flow for https://doi.org/10.1200%2FJCO.2018.36.15_suppl.9023?
• Profit of http://scholar.google.com/scholar_lookup?&title=Randomized%20phase%20II%20study%20of%20pembrolizumab%20after%20stereotactic%20body%20radiotherapy%20%28SBRT%29%20versus%20pembrolizumab%20alone%20in%20patients%20with%20advanced%20non-small%20cell%20lung%20cancer%3A%20The%20PEMBRO-RT%20study&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2018.36.15_suppl.9023&volume=36&issue=Suppl&publication_year=2018&author=Theelen%2CW&author=Peulen%2CH&author=Lalezari%2CF&author=Vries%2CJ&author=Langen%2CJ&author=Aerts%2CJ
• How much income does https://doi.org/10.1016%2Fj.ijrobp.2011.09.049 have?
• Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Maximizing%20tumor%20immunity%20with%20fractionated%20radiation&journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&doi=10.1016%2Fj.ijrobp.2011.09.049&volume=83&pages=1306-1310&publication_year=2012&author=Schaue%2CD&author=Ratikan%2CJA&author=Iwamoto%2CKS&author=McBride%2CWH
• https://doi.org/10.1158%2F1078-0432.CCR-04-2237's revenue stream
• Earnings of http://scholar.google.com/scholar_lookup?&title=The%20requirement%20of%20multimodal%20therapy%20%28vaccine%2C%20local%20tumor%20radiation%2C%20and%20reduction%20of%20suppressor%20cells%29%20to%20eliminate%20established%20tumors&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-04-2237&volume=11&pages=4533-4544&publication_year=2005&author=Kudo-Saito%2CC&author=Schlom%2CJ&author=Camphausen%2CK&author=Coleman%2CCN&author=Hodge%2CJW
• Learn how profitable https://doi.org/10.1016%2Fj.lungcan.2004.07.969 is on a monthly basis
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Palliative%20percutaneous%20radiotherapy%20in%20non-small-cell%20lung%20cancer&journal=Lung%20Cancer&doi=10.1016%2Fj.lungcan.2004.07.969&volume=45&issue=Suppl%202&pages=S239-S245&publication_year=2004&author=Budach%2CW&author=Belka%2CC
• https://doi.org/10.1016%2Fj.ejca.2008.10.026's total income per month
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=New%20response%20evaluation%20criteria%20in%20solid%20tumours%3A%20revised%20RECIST%20guideline%20%28version%201.1%29&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2008.10.026&volume=45&pages=228-247&publication_year=2009&author=Eisenhauer%2CEA&author=Therasse%2CP&author=Bogaerts%2CJ&author=Schwartz%2CLH&author=Sargent%2CD&author=Ford%2CR?
• What's the monthly income of https://doi.org/10.1089%2Fcbr.2012.1202?
• How much does http://scholar.google.com/scholar_lookup?&title=Abscopal%20regression%20of%20antigen%20disparate%20tumors%20by%20antigen%20cascade%20after%20systemic%20tumor%20vaccination%20in%20combination%20with%20local%20tumor%20radiation&journal=Cancer%20Biother%20Radiopharm&doi=10.1089%2Fcbr.2012.1202&volume=27&pages=12-22&publication_year=2012&author=Hodge%2CJW&author=Sharp%2CHJ&author=Gameiro%2CSR gross monthly?
• Find out how much http://scholar.google.com/scholar_lookup?&title=Current%20clinical%20trials%20testing%20the%20combination%20of%20immunotherapy%20with%20radiotherapy&journal=J%20Immunother%20Cancer&doi=10.1186%2Fs40425-016-0156-7&volume=4&publication_year=2016&author=Kang%2CJ&author=Demaria%2CS&author=Formenti%2CS earns monthly
• Earnings of http://scholar.google.com/scholar_lookup?&title=A%20phase%20I%20study%20of%20combination%20vaccine%20treatment%20of%20five%20therapeutic%20epitope-peptides%20for%20metastatic%20colorectal%20cancer%3B%20safety%2C%20immunological%20response%2C%20and%20clinical%20outcome&journal=J%20Transl%20Med&doi=10.1186%2F1479-5876-12-63&volume=12&publication_year=2014&author=Hazama%2CS&author=Nakamura%2CY&author=Takenouchi%2CH&author=Suzuki%2CN&author=Tsunedomi%2CR&author=Inoue%2CY
• Earnings of https://doi.org/10.1200%2FJCO.2007.11.5980
• http://scholar.google.com/scholar_lookup?&title=Phase%20II%20randomized%20controlled%20trial%20of%20an%20epidermal%20growth%20factor%20vaccine%20in%20advanced%20non-small-cell%20lung%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2007.11.5980&volume=26&pages=1452-1458&publication_year=2008&author=Neninger%20Vinageras%2CE&author=Torre%2CA&author=Osorio%20Rodr%C3%ADguez%2CM&author=Catal%C3%A1%20Ferrer%2CM&author=Bravo%2CI&author=Mendoza%20del%20Pino%2CM's financial summary
• How much does https://doi.org/10.1158%2F1078-0432.CCR-14-0202 net monthly?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Phase%20II%20clinical%20trial%20of%20multiple%20peptide%20vaccination%20for%20advanced%20head%20and%20neck%20cancer%20patients%20revealed%20induction%20of%20immune%20responses%20and%20improved%20OS&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-14-0202&volume=21&pages=312-321&publication_year=2015&author=Yoshitake%2CY&author=Fukuma%2CD&author=Yuno%2CA&author=Hirayama%2CM&author=Nakayama%2CH&author=Tanaka%2CT generate?
• What's the monthly income of https://doi.org/10.1038%2Fni889?
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Lineage%20relationship%20and%20protective%20immunity%20of%20memory%20CD8%20T%20cell%20subsets&journal=Nat%20Immunol&doi=10.1038%2Fni889&volume=4&pages=225-234&publication_year=2003&author=Wherry%2CEJ&author=Teichgr%C3%A4ber%2CV&author=Becker%2CTC&author=Masopust%2CD&author=Kaech%2CSM&author=Antia%2CR?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Harmonisation%20of%20short-term%20in%20vitro%20culture%20for%20the%20expansion%20of%20antigen-specific%20CD8%28%2B%29%20T%20cells%20with%20detection%20by%20ELISPOT%20and%20HLA-multimer%20staining&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-014-1593-0&volume=63&pages=1199-1211&publication_year=2014&author=Chudley%2CL&author=McCann%2CKJ&author=Coleman%2CA&author=Cazaly%2CAM&author=Bidmon%2CN&author=Britten%2CCM generate?
• Find out how much https://doi.org/10.1038%2Fbjc.2014.79 earns monthly
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Expanding%20the%20use%20of%20monoclonal%20antibody%20therapy%20of%20cancer%20by%20using%20ionising%20radiation%20to%20upregulate%20antibody%20targets&journal=Br%20J%20Cancer&doi=10.1038%2Fbjc.2014.79&volume=110&pages=1472-1480&publication_year=2014&author=Wattenberg%2CMM&author=Kwilas%2CAR&author=Gameiro%2CSR&author=Dicker%2CAP&author=Hodge%2CJW?
• See how much https://doi.org/10.1084%2Fjem.20082492 makes per month
• What's the income of http://scholar.google.com/scholar_lookup?&title=Blockade%20of%20CTLA-4%20on%20both%20effector%20and%20regulatory%20T%20cell%20compartments%20contributes%20to%20the%20antitumor%20activity%20of%20anti-CTLA-4%20antibodies&journal=J%20Exp%20Med&doi=10.1084%2Fjem.20082492&volume=206&pages=1717-1725&publication_year=2009&author=Peggs%2CKS&author=Quezada%2CSA&author=Chambers%2CCA&author=Korman%2CAJ&author=Allison%2CJP?
• Profit of https://doi.org/10.1038%2Fnature23003
• How much profit is http://scholar.google.com/scholar_lookup?&title=Personalized%20RNA%20mutanome%20vaccines%20mobilize%20poly-specific%20therapeutic%20immunity%20against%20cancer&journal=Nature&doi=10.1038%2Fnature23003&volume=547&pages=222-226&publication_year=2017&author=Sahin%2CU&author=Derhovanessian%2CE&author=Miller%2CM&author=Kloke%2CB-P&author=Simon%2CP&author=L%C3%B6wer%2CM making per month?
• Revenue of https://doi.org/10.1038%2Fnature22991
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=An%20immunogenic%20personal%20neoantigen%20vaccine%20for%20patients%20with%20melanoma&journal=Nature&doi=10.1038%2Fnature22991&volume=547&pages=217-221&publication_year=2017&author=Ott%2CPA&author=Hu%2CZ&author=Keskin%2CDB&author=Shukla%2CSA&author=Sun%2CJ&author=Bozym%2CDJ?
• How much does https://doi.org/10.1016%2FS0140-6736%2817%2931665-3 net monthly?
• Profit of http://scholar.google.com/scholar_lookup?&title=Safety%20and%20immunogenicity%20of%20a%20mRNA%20rabies%20vaccine%20in%20healthy%20adults%3A%20an%20open-label%2C%20non-randomised%2C%20prospective%2C%20first-in-human%20phase%201%20clinical%20trial&journal=Lancet&doi=10.1016%2FS0140-6736%2817%2931665-3&volume=390&pages=1511-1520&publication_year=2017&author=Alberer%2CM&author=Gnad-Vogt%2CU&author=Hong%2CHS&author=Mehr%2CKT&author=Backert%2CL&author=Finak%2CG
• How much does https://doi.org/10.1172%2FJCI80008 pull in?
• http://scholar.google.com/scholar_lookup?&title=Tumor%20neoantigens%3A%20building%20a%20framework%20for%20personalized%20cancer%20immunotherapy&journal=J%20Clin%20Invest&doi=10.1172%2FJCI80008&volume=125&pages=3413-3421&publication_year=2015&author=Gubin%2CMM&author=Artyomov%2CMN&author=Mardis%2CER&author=Schreiber%2CRD's total income per month
• What's the income of https://doi.org/10.1093%2Fintimm%2Fdxw026?
• What's http://scholar.google.com/scholar_lookup?&title=Targeting%20neoantigens%20for%20cancer%20immunotherapy&journal=Int%20Immunol&doi=10.1093%2Fintimm%2Fdxw026&volume=28&pages=365-370&publication_year=2016&author=Lu%2CY-C&author=Robbins%2CPF's gross income?
• Learn how profitable https://doi.org/10.1038%2Fni.3682 is on a monthly basis
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=%E2%80%9CFinal%20common%20pathway%E2%80%9D%20of%20human%20cancer%20immunotherapy%3A%20targeting%20random%20somatic%20mutations&journal=Nat%20Immunol&doi=10.1038%2Fni.3682&volume=18&pages=255-262&publication_year=2017&author=Tran%2CE&author=Robbins%2CPF&author=Rosenberg%2CSA?
• How much money does https://doi.org/10.1038%2Fnrc.2016.154 make?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Targeting%20neoantigens%20to%20augment%20antitumour%20immunity&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc.2016.154&volume=17&pages=209-222&publication_year=2017&author=Yarchoan%2CM&author=Johnson%2CBA&author=Lutz%2CER&author=Laheru%2CDA&author=Jaffee%2CEM
• Financial intake of https://citation-needed.springer.com/v2/references/10.1186/s40425-019-0520-5?format=refman&flavour=references
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Alexandros%20Papachristofilou generate monthly?
• What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Alexandros%20Papachristofilou%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Madeleine%20M.%20Hipp
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Madeleine%20M.%20Hipp%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ute%20Klinkhardt bring in each month?
• How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ute%20Klinkhardt%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
• What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Martin%20Fr%C3%BCh each month?
• What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Martin%20Fr%C3%BCh%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Martin%20Sebastian's revenue stream
• What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Martin%20Sebastian%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Christian%20Weiss generate?
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Christian%20Weiss%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
• What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Miklos%20Pless?
• What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Miklos%20Pless%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Richard%20Cathomas's revenue stream
• Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Richard%20Cathomas%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Wolfgang%20Hilbe generate?
• Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Wolfgang%20Hilbe%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
• Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Georg%20Pall
• What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Georg%20Pall%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What is the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Thomas%20Wehler?
• What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Thomas%20Wehler%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J%C3%BCrgen%20Alt
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J%C3%BCrgen%20Alt%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
• How much cash flow does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Helge%20Bischoff have monthly?
• How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Helge%20Bischoff%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
• Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Michael%20Gei%C3%9Fler
• What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Michael%20Gei%C3%9Fler%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How profitable is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Frank%20Griesinger?
• Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Frank%20Griesinger%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Karl-Josef%20Kallen
• Find out how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Karl-Josef%20Kallen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earns monthly
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Mariola%20Fotin-Mleczek make?
• What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Mariola%20Fotin-Mleczek%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Andreas%20Schr%C3%B6der produce monthly?
• What's the financial outcome of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Andreas%20Schr%C3%B6der%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Birgit%20Scheel pull in monthly?
• Earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Birgit%20Scheel%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How profitable is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Anke%20Muth?
• What are the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Anke%20Muth%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Learn how profitable https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tobias%20Seibel is on a monthly basis
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tobias%20Seibel%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's total income per month
• What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Claudia%20Stosnach?
• What are the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Claudia%20Stosnach%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Fatma%20Doener earn?
• What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Fatma%20Doener%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Henoch%20S.%20Hong
• What's the financial outcome of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Henoch%20S.%20Hong%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Sven%20D.%20Koch's gross income?
• Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Sven%20D.%20Koch%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What are the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ulrike%20Gnad-Vogt?
• Learn how profitable https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ulrike%20Gnad-Vogt%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en is on a monthly basis
• Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Alfred%20Zippelius
• What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Alfred%20Zippelius%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Income figures for https://static-content.springer.com/esm/art%3A10.1186%2Fs40425-019-0520-5/MediaObjects/40425_2019_520_MOESM1_ESM.pdf
• How much money does https://static-content.springer.com/esm/art%3A10.1186%2Fs40425-019-0520-5/MediaObjects/40425_2019_520_MOESM2_ESM.pdf make?
• What's the financial gain of https://static-content.springer.com/esm/art%3A10.1186%2Fs40425-019-0520-5/MediaObjects/40425_2019_520_MOESM3_ESM.pdf?
• Learn about the earnings of https://static-content.springer.com/esm/art%3A10.1186%2Fs40425-019-0520-5/MediaObjects/40425_2019_520_MOESM4_ESM.pdf
• What's https://static-content.springer.com/esm/art%3A10.1186%2Fs40425-019-0520-5/MediaObjects/40425_2019_520_MOESM5_ESM.pdf's gross income?
• How much profit does https://static-content.springer.com/esm/art%3A10.1186%2Fs40425-019-0520-5/MediaObjects/40425_2019_520_MOESM6_ESM.pdf generate?
• What's https://static-content.springer.com/esm/art%3A10.1186%2Fs40425-019-0520-5/MediaObjects/40425_2019_520_MOESM7_ESM.pdf's gross income?
• https://static-content.springer.com/esm/art%3A10.1186%2Fs40425-019-0520-5/MediaObjects/40425_2019_520_MOESM8_ESM.pdf's total income per month
• How much profit does https://static-content.springer.com/esm/art%3A10.1186%2Fs40425-019-0520-5/MediaObjects/40425_2019_520_MOESM9_ESM.pdf make?
• https://static-content.springer.com/esm/art%3A10.1186%2Fs40425-019-0520-5/MediaObjects/40425_2019_520_MOESM10_ESM.pdf's revenue stream
• Explore the financials of https://static-content.springer.com/esm/art%3A10.1186%2Fs40425-019-0520-5/MediaObjects/40425_2019_520_MOESM11_ESM.pdf
• How much money does http://creativecommons.org/licenses/by/4.0/ make?
• How much cash flow does http://creativecommons.org/publicdomain/zero/1.0/ have monthly?
• How much does https://s100.copyright.com/AppDispatchServlet?title=Phase%20Ib%20evaluation%20of%20a%20self-adjuvanted%20protamine%20formulated%20mRNA-based%20active%20cancer%20immunotherapy%2C%20BI1361849%20%28CV9202%29%2C%20combined%20with%20local%20radiation%20treatment%20in%20patients%20with%20stage%20IV%20non-small%20cell%20lung%20cancer&author=Alexandros%20Papachristofilou%20et%20al&contentID=10.1186%2Fs40425-019-0520-5©right=The%20Author%28s%29.&publication=2051-1426&publicationDate=2019-02-08&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY%20%2B%20CC0 make?
• How much does https://crossmark.crossref.org/dialog/?doi=10.1186/s40425-019-0520-5 pull in?
• How much revenue does https://citation-needed.springer.com/v2/references/10.1186/s40425-019-0520-5?format=refman&flavour=citation bring in?
• https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral's financial summary
• How much money does https://www.springernature.com/gp/products make?
• Profit of https://www.springernature.com/gp/librarians
• How much revenue does https://www.springernature.com/gp/societies produce monthly?
• https://www.springernature.com/gp/partners's total income per month
• How much revenue does https://www.springer.com/ produce monthly?
• See how much https://www.nature.com/ makes per month
• How much does https://www.biomedcentral.com/ rake in every month?
• How much cash flow does https://www.palgrave.com/ have monthly?
• How much profit is https://www.apress.com/ making per month?
• What are the earnings of https://www.springernature.com/gp/legal/ccpa?
• Learn about the earnings of https://www.springernature.com/gp/info/accessibility
• How much does https://support.springernature.com/en/support/home bring in each month?
• What's the financial outcome of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
• https://www.springernature.com/'s total income per month

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js